<code id='C89DF6E28D'></code><style id='C89DF6E28D'></style>
    • <acronym id='C89DF6E28D'></acronym>
      <center id='C89DF6E28D'><center id='C89DF6E28D'><tfoot id='C89DF6E28D'></tfoot></center><abbr id='C89DF6E28D'><dir id='C89DF6E28D'><tfoot id='C89DF6E28D'></tfoot><noframes id='C89DF6E28D'>

    • <optgroup id='C89DF6E28D'><strike id='C89DF6E28D'><sup id='C89DF6E28D'></sup></strike><code id='C89DF6E28D'></code></optgroup>
        1. <b id='C89DF6E28D'><label id='C89DF6E28D'><select id='C89DF6E28D'><dt id='C89DF6E28D'><span id='C89DF6E28D'></span></dt></select></label></b><u id='C89DF6E28D'></u>
          <i id='C89DF6E28D'><strike id='C89DF6E28D'><tt id='C89DF6E28D'><pre id='C89DF6E28D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:focus    Page View:4
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          The problems with dementia villages
          The problems with dementia villages

          AdobeRecently,dementiavillageshavegainedpopularityinEuropeandAustraliaasanall-in-onesolutiontocaring

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          STAT Readout: Friday, Oct. 20 biotech updates

          SuzanneKreiter/GlobestaffWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourb